Correlation Engine 2.0
Clear Search sequence regions


  • adults (2)
  • allodynia (9)
  • ampa receptors (2)
  • AMPARs (1)
  • amygdala (2)
  • analgesia (1)
  • anti- igg (1)
  • antibodies (4)
  • BCA (1)
  • behaviors (4)
  • blot western (1)
  • blue (1)
  • brain (12)
  • cases (2)
  • central nervous system (6)
  • china (3)
  • chronic pain (27)
  • cognitive impairment (1)
  • control group (6)
  • Ctrl (1)
  • culture cell (1)
  • cytokines (10)
  • direct (1)
  • edema (4)
  • egta (1)
  • embryos (1)
  • ether (1)
  • filaments (3)
  • gas (1)
  • glia (2)
  • groups control (1)
  • hepes (1)
  • hoechst 33258 (3)
  • horseradish (2)
  • human (1)
  • hyperalgesia (2)
  • immun (1)
  • japan (1)
  • layer (2)
  • macrophages (1)
  • methyl (1)
  • mgcl2 (1)
  • mice (26)
  • microglia (15)
  • mood disorders (1)
  • nervous (1)
  • neurons (27)
  • NF κB (1)
  • NMDA receptor (3)
  • NMDARs (2)
  • oil (1)
  • olive (1)
  • pain treatment (1)
  • patients (2)
  • penicillin (1)
  • phase (1)
  • praeruptorin c (85)
  • protect (1)
  • protein level (2)
  • proteins control (1)
  • protocols (1)
  • pvdf (1)
  • reagents (1)
  • receptors (4)
  • relief (1)
  • researches (1)
  • respond (1)
  • serum (2)
  • signals (2)
  • sleep (1)
  • slides (2)
  • spinal cord (1)
  • STAT3 (1)
  • streptomycin (1)
  • stroke (1)
  • targets drugs (1)
  • thalamus (1)
  • TNF α (10)
  • tris (1)
  • tris- buffer (1)
  • triton x- 100 (2)
  • trypsin (1)
  • tween 20 (1)
  • western blot (7)
  • β actin (2)
  • Sizes of these terms reflect their relevance to your search.

    Chronic pain is highly prevalent worldwide and severely affects daily lives of patients and family members. Praeruptorin C (Pra-C) is a main active ingredient derived from Peucedanum praeruptorum Dunn, traditionally used as antibechic, anti-bronchitis and anti-hypertension drug. Here, we evaluated the effects of Pra-C in a chronic inflammatory pain mouse model induced by complete Freund's adjuvant (CFA) injection. Pra-C (3 mg/kg) treatment for just 3 days after CFA challenge relieved CFA-induced mechanical allodynia and hindpaw edema in mice. In the anterior cingulate cortex (ACC), Pra-C treatment inhibited microglia activation and reduced levels of proinflammatory cytokines, TNF-α and IL-1β, and suppressed upregulation of glutamate receptors caused by CFA injection. In addition, Pra-C attenuated neuronal hyperexcitability in ACC of CFA-injected mice. In vitro studies confirmed the analgesic effect of Pra-C was due to its inhibitory ability on microglial activation. In conclusion, Pra-C administration had a certain effect on relieving chronic pain by inhibiting microglial activation, attenuating proinflammatory cytokine releasing and regulating excitatory synaptic proteins in the ACC of the CFA-injected mice.

    Citation

    Dan-Jie Su, Long-Fei Li, Sai-Ying Wang, Qi Yang, Yu-Jing Wu, Ming-Gao Zhao, Le Yang. Pra-C exerts analgesic effect through inhibiting microglial activation in anterior cingulate cortex in complete Freund's adjuvant-induced mouse model. Molecular pain. 2021 Feb 16;17:1744806921990934


    PMID: 33590786

    View Full Text